|Bid||159.45 x 800|
|Ask||162.89 x 900|
|Day's Range||156.39 - 159.74|
|52 Week Range||132.24 - 243.52|
|Beta (5Y Monthly)||0.52|
|PE Ratio (TTM)||25.96|
|Earnings Date||Jan 24, 2024 - Jan 29, 2024|
|Forward Dividend & Yield||1.92 (1.20%)|
|Ex-Dividend Date||Nov 08, 2023|
|1y Target Est||178.38|
Subscribe to Yahoo Finance Plus to view Fair Value for RMD
Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ResMed Inc (NYSE:RMD), a global leader in the development, manufacturing, and marketing of innovative medical products for the treatment and management of respiratory disorders, with a focus on sleep-disordered breathing, has recently witnessed a significant insider sell by its Chief Financial Officer (CFO), Brett Sandercock.